We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-4.69%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.82B
AUM Growth
-$206M
Cap. Flow
-$49M
Cap. Flow %
-2.7%
Top 10 Hldgs %
31.37%
Holding
196
New
13
Increased
107
Reduced
57
Closed
16

Top Buys

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$23.1M
2
PS
Pluralsight, Inc. Class A Common Stock
PS
+$20.8M
3
CHGG icon
Chegg
CHGG
+$20.6M
4
SPSC icon
SPS Commerce
SPSC
+$18.8M
5
ETSY icon
Etsy
ETSY
+$12M

Top Sells

Rank Stock Value
1
COUP
Coupa Software Incorporated
COUP
+$27.8M
2
TTD icon
Trade Desk
TTD
+$25.9M
3
SMAR
Smartsheet Inc.
SMAR
+$18.3M
4
CSGP icon
CoStar Group
CSGP
+$17.8M
5
MIME
Mimecast Limited
MIME
+$15.9M

Sector Composition

Rank Sector Weight
1 Technology 34.3%
2 Healthcare 19.73%
3 Industrials 13.65%
4 Consumer Discretionary 10.97%
5 Real Estate 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITRM
151
DELISTED
Iterum Therapeutics
ITRM
$1.4M 0.08%
16,148
+624
+4% +$60.8K
EDIT icon
152
Editas Medicine
EDIT
$442M
$1.25M 0.07%
55,017
+4,221
+8% +$105K
MIXT
153
DELISTED
MIX TELEMATICS LIMITED
MIXT
$1.16M 0.06%
83,186
+44,474
+115% +$650K
CTMX icon
154
CytomX Therapeutics
CTMX
$754M
$1.13M 0.06%
153,397
+6,174
+4% +$60.9K
COHR icon
155
Coherent
COHR
$74.2B
$962K 0.05%
+27,312
New +$1.04M
XENE icon
156
Xenon Pharmaceuticals
XENE
$6.12B
$959K 0.05%
106,459
+8,200
+8% +$77.5K
CDTX
157
DELISTED
Cidara Therapeutics
CDTX
$926K 0.05%
23,208
+1,342
+6% +$45.1K
SGMO
158
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$920K 0.05%
101,619
+7,370
+8% +$82.7K
MTCH icon
159
Match Group
MTCH
$8.55B
$918K 0.05%
12,850
+1,776
+16% +$138K
MLNT
160
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$917K 0.05%
240,771
+18,200
+8% +$65.6K
ETTX
161
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$840K 0.05%
141,012
+2,471
+2% +$16.6K
NTLA icon
162
Intellia Therapeutics
NTLA
$1.67B
$797K 0.04%
59,691
+4,528
+8% +$72.2K
GTT
163
DELISTED
GTT Communications, Inc.
GTT
$769K 0.04%
81,627
+2,690
+3% +$30.3K
PRTK
164
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$768K 0.04%
177,873
+11,361
+7% +$45.4K
TRTN
165
DELISTED
Triton International Limited
TRTN
$767K 0.04%
22,680
-39,354
-63% -$1.29M
AKTS
166
DELISTED
Akoustis Technologies Inc
AKTS
$766K 0.04%
+98,887
New +$650K
CAI
167
DELISTED
CAI International, Inc.
CAI
$693K 0.04%
31,849
-84,092
-73% -$1.85M
SHSP
168
DELISTED
SharpSpring, Inc.
SHSP
$576K 0.03%
+59,338
New +$655K
TTOO
169
DELISTED
T2 Biosystems, Inc
TTOO
$544K 0.03%
+44
New +$353K
NBRV
170
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$472K 0.03%
944
+17
+2% +$9.59K
COLL icon
171
Collegium Pharmaceutical
COLL
$956M
$467K 0.03%
40,706
-121,507
-75% -$1.39M
LYV icon
172
Live Nation Entertainment
LYV
$42.1B
$448K 0.02%
6,748
-676
-9% -$47.3K
TACT icon
173
Transact Technologies
TACT
$58.5M
$437K 0.02%
+35,964
New +$432K
JNCE
174
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$409K 0.02%
122,912
+6,832
+6% +$27.3K
STIM icon
175
Neuronetics
STIM
$166M
$372K 0.02%
44,729
-88,920
-67% -$971K
4 5 6
7
8

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Granahan Investment Management held 196 positions worth $1.82B, down 10% from $2.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Granahan Investment Management's Q3 2019 filing shows 13 new, 107 increased, 57 reduced and 16 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 964,081 shares worth $16.2M. The largest sale was Coupa Software Incorporated, an estimated $27.8M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q3 2019 buy was Pluralsight, Inc. Class A Common Stock: 964,081 shares worth $16.2M.
  • Granahan Investment Management added most to Enphase Energy in Q3 2019, an estimated $23.1M increase.
  • Granahan Investment Management's biggest Q3 2019 reduction was Coupa Software Incorporated, cutting an estimated $27.8M.
  • Granahan Investment Management fully exited Trade Desk in Q3 2019, selling an estimated $25.9M.
  • Granahan Investment Management's ten largest holdings make up 31% of its $1.82B portfolio in Q3 2019.
  • Granahan Investment Management opened 13 new positions and closed 16 in Q3 2019.
  • Granahan Investment Management's portfolio value fell 10% quarter-over-quarter to $1.82B.

Based on Granahan Investment Management's 13F filing for Q3 2019, filed 15 Nov 2019.